Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Gregg Y"'
Autor:
Thomas, Sarah P., Fathy, Ramie, Aepli, Savannah, Clancy, Caitlin B., Lipschik, Gregg Y., Simpson, Scott A., Katz, Sharyn I., Doms, Robert W., Nachiappan, Arun C.
Publikováno v:
In Academic Radiology May 2022 29 Supplement 5:S82-S88
Autor:
Sarah P. Thomas, Ramie Fathy, Savannah Aepli, Caitlin B. Clancy, Gregg Y. Lipschik, Scott A. Simpson, Sharyn I. Katz, Robert W. Doms, Arun C. Nachiappan
Publikováno v:
Academic Radiology. 29:S82-S88
We aim to compare Choose Your Own Adventure (CYOA) presentation format with linear case format as educational methods for teaching a radiology small group session to medical students.A radiology small group session was held for preclinical second-yea
Publikováno v:
The Journal of Infectious Diseases, 1998 Jan 01. 177(1), 182-187.
Externí odkaz:
https://www.jstor.org/stable/30107669
Publikováno v:
The Journal of Infectious Diseases, 1991 May 01. 163(5), 1121-1127.
Externí odkaz:
https://www.jstor.org/stable/30132508
Autor:
Lipschik, Gregg Y., Gill, Vee J.
Publikováno v:
Lancet. 7/25/1992, Vol. 340 Issue 8813, p203. 4p. 1 Chart.
Autor:
Gregg Y. Lipschik, Luis M. Seijo
Publikováno v:
Clinical Pulmonary Medicine. 7:170-177
Autor:
Jeffrey R. Dichter, Birgitte Nybo Jensen, Jette Junge, Gregg Y. Lipschik, Jens D Lundgren, Thomas Benfield, R. P. van Steenwijk, James H. Shelhamer, T.L. Nielsen
Publikováno v:
Respiratory medicine, 89(4), 285-290. W.B. Saunders Ltd
Pneumocystis carinii pneumonia (PCP) may cause severe respiratory distress. This is believed to be partly caused by the accumulation of neutrophils in the lung. Interleukin-8 (IL-8) and leukotriene B4 (LTB4) are potent neutrophil chemo-attractants an
Autor:
Frederick P. Ognibene, Marion G. Lawrence, Alan G. D. Hoffman, Gregg Y. Lipschik, Anthony F. Suffredini, Joseph A. Kovacs, James H. Shelhamer, Henry Masur
Publikováno v:
Chest. 102:1730-1736
We assessed qualitative and quantitative differences in surfactant lipid composition of bronchoalveolar lavage (BAL) fluid in patients with acquired immune deficiency syndrome (AIDS) and Pneumocystis carinii (PC) pneumonia. Five normal volunteers and
Publikováno v:
Journal of Infectious Diseases. 163:1121-1127
Alpha-difluoromethylornithine (DFMO) is being used to treat Pneumocystis carinii pneumonia despite a lack of in vitro evidence supporting its antipneumocystis activity. DFMO is a specific inhibitor of ornithine decarboxylase, the rate-limiting enzyme